Cargando…
Self-Assembled Nanofibers Elicit Potent HPV16 E7-Specific Cellular Immunity And Abolish Established TC-1 Graft Tumor
BACKGROUND: Vaccines are one of the most promising strategies for immunotherapy of HPV associated tumors; however, they generally lack significant clinical efficacy at present. This inefficacy might be due to inefficient generation of anti-tumor cellular immune responses. PURPOSE: This study aimed t...
Autores principales: | Li, Sijin, Zhang, Qishu, Bai, Hongmei, Huang, Weiwei, Shu, Congyan, Ye, Chao, Sun, Wenjia, Ma, Yanbing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6794571/ https://www.ncbi.nlm.nih.gov/pubmed/31632028 http://dx.doi.org/10.2147/IJN.S214525 |
Ejemplares similares
-
Engineered outer membrane vesicle is potent to elicit HPV16E7-specific cellular immunity in a mouse model of TC-1 graft tumor
por: Wang, Shijie, et al.
Publicado: (2017) -
Chimeric HBcAg virus-like particles presenting a HPV 16 E7 epitope significantly suppressed tumor progression through preventive or therapeutic immunization in a TC-1-grafted mouse model
por: Chu, Xiaojie, et al.
Publicado: (2016) -
Anti-outer Membrane Vesicle Antibodies Increase Antibiotic Sensitivity of Pan-Drug-Resistant Acinetobacter baumannii
por: Huang, Weiwei, et al.
Publicado: (2019) -
Recombinant VLPs empower RBM peptides showing no immunogenicity in native SARS-COV-2 protein to elicit a robust neutralizing antibody response
por: Long, Qiong, et al.
Publicado: (2022) -
Chimeric Infectious Bursal Disease Virus-Like Particles as Potent Vaccines for Eradication of Established HPV-16 E7–Dependent Tumors
por: Martin Caballero, Juan, et al.
Publicado: (2012)